Does WARFARIN Cause Pulmonary arterial hypertension? 58 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 58 reports of Pulmonary arterial hypertension have been filed in association with WARFARIN (Warfarin Sodium). This represents 0.1% of all adverse event reports for WARFARIN.
58
Reports of Pulmonary arterial hypertension with WARFARIN
0.1%
of all WARFARIN reports
30
Deaths
40
Hospitalizations
How Dangerous Is Pulmonary arterial hypertension From WARFARIN?
Of the 58 reports, 30 (51.7%) resulted in death, 40 (69.0%) required hospitalization, and 11 (19.0%) were considered life-threatening.
Is Pulmonary arterial hypertension Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for WARFARIN. However, 58 reports have been filed with the FAERS database.
What Other Side Effects Does WARFARIN Cause?
International normalised ratio increased (5,622)
Haemorrhage (2,930)
Gastrointestinal haemorrhage (2,469)
Anaemia (2,409)
Drug interaction (2,056)
Fall (1,702)
Drug ineffective (1,658)
Epistaxis (1,498)
Contusion (1,467)
Dyspnoea (1,374)
What Other Drugs Cause Pulmonary arterial hypertension?
TREPROSTINIL (3,240)
MACITENTAN (2,390)
AMBRISENTAN (1,965)
SELEXIPAG (1,387)
EPOPROSTENOL (1,055)
BOSENTAN (778)
TADALAFIL (680)
SILDENAFIL (487)
RIOCIGUAT (436)
ILOPROST (284)